Gilead gets expanded approval for Epclusa

05:32 EDT 3 Aug 2017 | SmartBrief

Gilead Sciences has received approval from the FDA to expand the indication for Epclusa, or sofosbuvir 400 mg/velpatasvir 100 -More

Original Article: Gilead gets expanded approval for Epclusa


More From BioPortfolio on "Gilead gets expanded approval for Epclusa"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...